Cancer stem cell genomics: the quest for early markers of malignant progression

Página do item simplificado
dc.contributor.authorOkamoto, Oswaldo Keith [UNIFESP]
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.date.accessioned2016-01-24T13:58:44Z
dc.date.available2016-01-24T13:58:44Z
dc.date.issued2009-09-01
dc.description.abstractBiologically distinct populations of neoplastic stem cells have been identified in a variety of human cancers, in which they are associated with the initial steps of tumorigenesis. the intrinsic properties of self-renewal, clonogenicity and multipotency, along with a longer half-life within the body, may render normal adult stem cells more prone to accumulate genetic mutations leading to neoplastic transformation, as predicted by the cancer stem cell hypothesis. Tumor formation is also associated with the pluripotency of embryonic stem cells and may be induced as a consequence of complete dedifferentiation of mature cells, as recently reported for induced pluripotent stem cells. the tumor-initiating cell phenotype may result from genetic alterations affecting the expression of critical genes regulating typical stem cell processes such as self-renewal and pluripotency, in addition to genes determining stem cell senescence or longevity. Detailed genome-wide analysis of cancer stem cells and respective normal counterparts will help elucidate the cellular and molecular nature of tumors, providing fundamental information about the initial steps toward malignant transformation. Devising ways of detecting such genetic and epigenetic alterations and cell populations displaying them would allow medical interventions at the early phases of cancer development, thereby improving the chances of favorable clinical outcomes.en
dc.description.affiliationUniversidade Federal de São Paulo, Escola Paulista Med, Dept Neurol & Neurocirurgia, Disciplina Neurol Expt, BR-04023900 São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Escola Paulista Med, Dept Neurol & Neurocirurgia, Disciplina Neurol Expt, BR-04023900 São Paulo, Brazil
dc.description.sourceWeb of Science
dc.format.extent545-554
dc.identifierhttp://dx.doi.org/10.1586/ERM.09.40
dc.identifier.citationExpert Review of Molecular Diagnostics. London: Expert Reviews, v. 9, n. 6, p. 545-554, 2009.
dc.identifier.doi10.1586/ERM.09.40
dc.identifier.issn1473-7159
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/31808
dc.identifier.wosWOS:000270189800003
dc.language.isoeng
dc.publisherExpert Reviews
dc.relation.ispartofExpert Review of Molecular Diagnostics
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectbiotechnologyen
dc.subjectcanceren
dc.subjectcancer stem cellen
dc.subjectgenomicsen
dc.subjectmalignant transformationen
dc.subjecttargeted therapyen
dc.subjecttumorigenesisen
dc.titleCancer stem cell genomics: the quest for early markers of malignant progressionen
dc.typeinfo:eu-repo/semantics/article
Arquivos
Coleções
EPM - Outras produções